ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) traded at $0.45 at last check on current trade day and made an upward move of 3.45% on its previous day’s price.
Looking at the stock we see that its previous close was $0.44 and the beta (5Y monthly) reads 0.383 with the day’s price range being $0.4255 – $0.469. In terms of its 52-week price range, IPA has a high of $1.39 and a low of $0.27. The company’s stock has gained about 5.88% over that past 30 days.
ImmunoPrecise Antibodies Ltd has a market cap of $20.60 million and is expected to release its quarterly earnings report on 2025-Mar-27.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 7.89M, with a low of 7.2M and a high of 8.58M. The median projection represents growth squeezing down to 22.16% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 25.43M, or 3.72% up from figures reported last year.
On the other hand, looking at the outlook for the IPA stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of 50% Sell.
Looking further, we note the current price level is 10.91% off its SMA20 and 11.58% from its 50-day simple moving average. The RSI (14) is pointing at 56.16 while the volatility over the past week is 11.53% and jumps to 14.25% over the past one month. The beta value is 0.26, while the average true range (ATR) is currently pointing at 0.05.
Coming back to ImmunoPrecise Antibodies Ltd (NASDAQ:IPA), we note that the average 3-month trading volume was 2.27 million, while that of the preceding 10-day period stands at 0.47 million. Current shares outstanding are 45.77 million.
The insiders hold 13.30% of the company’s shares while institutions hold 7.75%. The data shows that short shares as of 2025-03-31, stood at 1.59 million at a short ratio of 0.72. This represents a 350.00 short interest in shares outstanding on 2025-03-31. Shares short fall in March from the previous month at 2.19 million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock 9.30% up in year-to-date price movement.
